who cannot take tirzepatide and autoimmune disease: what the research actually shows Tirzepatide for Medical Weight Loss
Description
One stat that blows me away is that 50% to 60% of GLP-1 users have switched their go-to retailer for groceries and household essentials since starting the drug, ODonnell says

In these cases, monitoring of the lower urinary tract including the urethra should at least be performed for 5 years, and monitoring of the upper urinary tract should be performed for the rest of the patients life
88 Serum DPP4 activity has been found to be elevated in individuals with T1DM, and this increase is associated with the duration of diabetes
The study compared the efficacy and safety of FDA-approved incretin-based therapies for weight management: tirzepatide, semaglutide, and liraglutide

Elevated levels have also been detected in patients with lupus, rosacea, and some forms of inflammatory bowel disease

These medications appear to reduce inflammatory cytokines, oxidative stress, and vascular injury markers that contribute to kidney damage
